Literature DB >> 24857353

IL1-β expression in multiple sclerosis.

Amir Hadi Maghzi1, Alireza Minagar2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24857353     DOI： 10.1016/j.jns.2014.05.009

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN： 0022-510X            Impact factor:   3.181


× No keyword cloud information.
  4 in total

1.  Papaverine inhibits lipopolysaccharide-induced microglial activation by suppressing NF-κB signaling pathway.

Authors:  Yalong Dang; Yalin Mu; Kun Wang; Ke Xu; Jing Yang; Yu Zhu; Bin Luo
Journal:  Drug Des Devel Ther       Date:  2016-02-26       Impact factor: 4.162

2.  Identification of rare genetic variation of NLRP1 gene in familial multiple sclerosis.

Authors:  Ales Maver; Polona Lavtar; Smiljana Ristić; Sanja Stopinšek; Saša Simčič; Keli Hočevar; Juraj Sepčić; Jelena Drulović; Tatjana Pekmezović; Ivana Novaković; Hodžić Alenka; Gorazd Rudolf; Saša Šega; Nada Starčević-Čizmarević; Anja Palandačić; Gordana Zamolo; Miljenko Kapović; Tina Likar; Borut Peterlin
Journal:  Sci Rep       Date:  2017-06-16       Impact factor: 4.379

3.  Apamin Suppresses LPS-Induced Neuroinflammatory Responses by Regulating SK Channels and TLR4-Mediated Signaling Pathways.

Authors:  Jihyun Park; Kyung Mi Jang; Kwan-Kyu Park
Journal:  Int J Mol Sci       Date:  2020-06-17       Impact factor: 5.923

4.  Evaluation of IL-1β and IL-6 Expression following EBNA-1 and BRLF-1 Peptide Treatment in Epstein-Barr Virus-Positive Multiple Sclerosis Patients.

Authors:  Roya Kianfar; Mehrdad Ravanshad; Mohammad Adel Ghiass; Nastaran Rafiee; Ali Shayeghpour; Ali Maleki
Journal:  Intervirology       Date:  2022-02-14       Impact factor: 2.294
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.